Logo image of INFN

INFINERA CORP (INFN) Stock Fundamental Analysis

USA - NASDAQ:INFN - US45667G1031 - Common Stock

6.64 USD
-0.01 (-0.15%)
Last: 2/27/2025, 8:00:01 PM
6.65 USD
+0.01 (+0.15%)
After Hours: 2/27/2025, 8:00:01 PM
Fundamental Rating

2

Overall INFN gets a fundamental rating of 2 out of 10. We evaluated INFN against 48 industry peers in the Communications Equipment industry. Both the profitability and financial health of INFN have multiple concerns. INFN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year INFN has reported negative net income.
INFN had a positive operating cash flow in the past year.
In the past 5 years INFN always reported negative net income.
In multiple years INFN reported negative operating cash flow during the last 5 years.
INFN Yearly Net Income VS EBIT VS OCF VS FCFINFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

INFN has a worse Return On Assets (-9.80%) than 62.75% of its industry peers.
INFN has a Return On Equity of -129.03%. This is in the lower half of the industry: INFN underperforms 78.43% of its industry peers.
Industry RankSector Rank
ROA -9.8%
ROE -129.03%
ROIC N/A
ROA(3y)-5.29%
ROA(5y)-7.71%
ROE(3y)-61%
ROE(5y)-56.84%
ROIC(3y)N/A
ROIC(5y)N/A
INFN Yearly ROA, ROE, ROICINFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 38.43%, INFN is in line with its industry, outperforming 49.02% of the companies in the same industry.
INFN's Gross Margin has improved in the last couple of years.
INFN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.12%
GM growth 5Y5.37%
INFN Yearly Profit, Operating, Gross MarginsINFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1

2. Health

2.1 Basic Checks

INFN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INFN has been increased compared to 1 year ago.
The number of shares outstanding for INFN has been increased compared to 5 years ago.
INFN has a worse debt/assets ratio than last year.
INFN Yearly Shares OutstandingINFN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
INFN Yearly Total Debt VS Total AssetsINFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that INFN is in the distress zone and has some risk of bankruptcy.
INFN's Altman-Z score of 0.01 is on the low side compared to the rest of the industry. INFN is outperformed by 68.63% of its industry peers.
INFN has a debt to FCF ratio of 117.95. This is a negative value and a sign of low solvency as INFN would need 117.95 years to pay back of all of its debts.
With a Debt to FCF ratio value of 117.95, INFN perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
INFN has a Debt/Equity ratio of 5.73. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.73, INFN is doing worse than 92.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF 117.95
Altman-Z 0.01
ROIC/WACCN/A
WACC8.48%
INFN Yearly LT Debt VS Equity VS FCFINFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

INFN has a Current Ratio of 1.51. This is a normal value and indicates that INFN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of INFN (1.51) is worse than 66.67% of its industry peers.
A Quick Ratio of 1.02 indicates that INFN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.02, INFN is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.02
INFN Yearly Current Assets VS Current LiabilitesINFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for INFN have decreased strongly by -457.37% in the last year.
The Revenue for INFN has decreased by -12.12% in the past year. This is quite bad
Measured over the past years, INFN shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-457.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-298.93%
Revenue 1Y (TTM)-12.12%
Revenue growth 3Y-0.16%
Revenue growth 5Y1.78%
Sales Q2Q%-8.62%

3.2 Future

The Earnings Per Share is expected to grow by 151.08% on average over the next years. This is a very strong growth
INFN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.20% yearly.
EPS Next Y326.09%
EPS Next 2Y151.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INFN Yearly Revenue VS EstimatesINFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
INFN Yearly EPS VS EstimatesINFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INFN. In the last year negative earnings were reported.
INFN is valuated quite expensively with a Price/Forward Earnings ratio of 25.04.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INFN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, INFN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 25.04
INFN Price Earnings VS Forward Price EarningsINFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as INFN.
INFN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 278.85
EV/EBITDA 324.21
INFN Per share dataINFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INFN's earnings are expected to grow with 151.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y151.08%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INFN!.
Industry RankSector Rank
Dividend Yield N/A

INFINERA CORP

NASDAQ:INFN (2/27/2025, 8:00:01 PM)

After market: 6.65 +0.01 (+0.15%)

6.64

-0.01 (-0.15%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners93.07%
Inst Owner Change-53.91%
Ins Owners1.39%
Ins Owner Change0%
Market Cap1.58B
Revenue(TTM)1.42B
Net Income(TTM)-150.34M
Analysts48
Price Target6.48 (-2.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.22%
Min Revenue beat(2)-13.76%
Max Revenue beat(2)-0.69%
Revenue beat(4)1
Avg Revenue beat(4)-5.96%
Min Revenue beat(4)-13.76%
Max Revenue beat(4)1.3%
Revenue beat(8)4
Avg Revenue beat(8)-3.07%
Revenue beat(12)6
Avg Revenue beat(12)-1.9%
Revenue beat(16)7
Avg Revenue beat(16)-1.81%
PT rev (1m)-1.16%
PT rev (3m)-1.16%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.32%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)2.86%
Revenue NY rev (3m)2.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.04
P/S 1.11
P/FCF 278.85
P/OCF 19.59
P/B 13.56
P/tB N/A
EV/EBITDA 324.21
EPS(TTM)-0.64
EYN/A
EPS(NY)0.27
Fwd EY3.99%
FCF(TTM)0.02
FCFY0.36%
OCF(TTM)0.34
OCFY5.11%
SpS5.96
BVpS0.49
TBVpS-0.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.8%
ROE -129.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.43%
FCFM 0.4%
ROA(3y)-5.29%
ROA(5y)-7.71%
ROE(3y)-61%
ROE(5y)-56.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.12%
GM growth 5Y5.37%
F-Score2
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF 117.95
Debt/EBITDA 102.98
Cap/Depr 120.34%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion 1243.91%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.02
Altman-Z 0.01
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)84.82%
Cap/Depr(5y)68.59%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-457.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-298.93%
EPS Next Y326.09%
EPS Next 2Y151.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.12%
Revenue growth 3Y-0.16%
Revenue growth 5Y1.78%
Sales Q2Q%-8.62%
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1485.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year854.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.96%
OCF growth 3Y42.13%
OCF growth 5YN/A

INFINERA CORP / INFN FAQ

What is the fundamental rating for INFN stock?

ChartMill assigns a fundamental rating of 2 / 10 to INFN.


Can you provide the valuation status for INFINERA CORP?

ChartMill assigns a valuation rating of 2 / 10 to INFINERA CORP (INFN). This can be considered as Overvalued.


Can you provide the profitability details for INFINERA CORP?

INFINERA CORP (INFN) has a profitability rating of 1 / 10.


How financially healthy is INFINERA CORP?

The financial health rating of INFINERA CORP (INFN) is 1 / 10.


Can you provide the expected EPS growth for INFN stock?

The Earnings per Share (EPS) of INFINERA CORP (INFN) is expected to grow by 326.09% in the next year.